PKCζ As a Promising Therapeutic Target for TNFα-induced Inflammatory Disorders in Chronic Cutaneous Wounds

Jian Zhang,Xuekang Yang,Hongtao Wang,Bin Zhao,Xue Wu,Linlin Su,Songtao Xie,Yunchuan Wang,Jun Li,Jiaqi Liu,Mengdong Liu,Fu Han,Ting He,Wei Zhang,Ke Tao,Dahai Hu
DOI: https://doi.org/10.3892/ijmm.2017.3144
IF: 5.314
2017-01-01
International Journal of Molecular Medicine
Abstract:Protein kinase C zeta (PKC zeta) is a member of the atypical protein kinase C family. Its roles in macrophages or skin-resident keratinocytes have not been fully evaluated. In this study, we provide evidence that PKC zeta mediates lipopolysaccharide (LPS)-induced tumor necrosis factor alpha (TNF alpha) gene expression in the mouse macrophage cell line, RAW264.7. TNF alpha has been proven to be one of the main culprits of chronic wounds and impaired acute wounds, which are characterized by excessive inflammation, enhanced proteolysis and reduced matrix deposition. Among the multiple effects of TNF alpha on keratinocytes, the induction of chemokines which are indispensable factors involved in the massive infiltration of various inflammatory cells into skin lesions serves as a crucial mechanism. In the present study, we found that PKC zeta inhibitor or its specific siRNA inhibited the TNF alpha-induced upregulation in the levels of the chemokines, interleukin (IL)-8, monocyte chemotactic protein-1 (MCP-1) and intercellular cell adhesion molecule-1 (ICAM-1) in HaCaT keratinocytes. Moreover, under a disrupted inflammatory environment, activated keratinocytes can synthesize large amounts of matrix metalloproteinases (MMP), which has a negative effect on tissue remodeling. We discovered that TNF alpha promoted the expression of MMP9 in a PKC zeta-dependent manner. Further experiments revealed that nuclear factor-kappa B (NF-kappa B) was a key downstream molecule of PKC zeta. In addition, as shown in vitro, PKC zeta was not involved in the TNF alpha-induced decrease in HaCaT cell migration and proliferation. In vivo experiments demonstrated that TNF alpha-induced wound closure impairment and inflammatory disorders were significantly attenuated in the PKC zeta inhibitor group. On the whole, our findings suggest that PKC zeta is a crucial regulator in LPS- or TNF alpha-induced inflammatory responses in RAW264.7 cells and HaCaT keratinocytes, and that PKC zeta/NF-kappa B signaling may be a potential target for interventional therapy for TNF alpha-induced skin inflammatory injury.
What problem does this paper attempt to address?